Joseph M. Metzger - Concepedia

Author

Joseph M. Metzger

Also Known As

Anil Thankappan, J M Metzger, J Metzger, J. M. METZGER, J. M. Metzger, J. Metzger, J.-M. Metzger, J.M. Metzger, JOSEPH METZGER, Joseph M Metzger

319

Publications

14.7K

Citations

H-Index

182

Concepts

All Affiliations

University of Michigan Merck & Co., Inc., Rahway, NJ, USA (United States)University of Minnesota Medical Center University of Minnesota University of Wisconsin–Madison

About

Joseph M. Metzger is an author at University of Michigan specializing in medicine, physiology, and cellular physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	99	8.7K
2	Health Sciences	25	33	3.5K
3	Natural Sciences	19	23	1.1K
4	Engineering	18	19	1.4K
5	Public Health	3	3	1.2K

Joseph M. Metzger

174

Publications

13.4K

Citations

H-Index

Page 1

	Year	Citations
An integrative genomics approach to infer causal associations between gene expression and disease Eric E. Schadt, John R. Lamb, Xia Yang, Nature Genetics Genome-wide Association StudyCausal AssociationsEpidemiologyGene-environment InteractionFunctional Genomics	2005	1K
Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass Airu S. Chen, Donald J. Marsh, Myrna E. Trumbauer, Nature Genetics ObesityMetabolic SyndromeEnergy HomeostasisBody CompositionMedicine	2000	891
Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism Donald J. Marsh, Drew T. Weingarth, Dawn E. Novi, Proceedings of the National Academy of Sciences Metabolic RateGastrointestinal Peptide HormoneObesityMetabolic SyndromeMch 1	2002	546
11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice Anne Hermanowski‐Vosatka, James M. Balkovec, Kang Cheng, The Journal of Experimental Medicine	2005	362
L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-<i>t</i>-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor John W. Gillard, A W Ford‐Hutchinson, Chi-Chung Chan, Canadian Journal of Physiology and Pharmacology	1989	328
Dystrophin‐deficient <i>mdx</i> mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma Jeffrey S. Chamberlain, Joseph M. Metzger, Morayma Reyes, The FASEB Journal	2007	318
Dystrophic heart failure blocked by membrane sealant poloxamer Soichiro Yasuda, DeWayne Townsend, Daniel E. Michele, Nature Heart FailureStructural Heart DiseasePhysiologyMembrane Sealant PoloxamerMedicine	2005	314
Contemporary Cardiac Issues in Duchenne Muscular Dystrophy Elizabeth M. McNally, Jonathan R. Kaltman, D. Woodrow Benson, Circulation CardiomyopathyHeart FailureContemporary Cardiac IssuesMedicineCardiology	2015	312
Variations in cross-bridge attachment rate and tension with phosphorylation of myosin in mammalian skinned skeletal muscle fibers. Implications for twitch potentiation in intact muscle. Joseph M. Metzger, Marion L. Greaser, R L Moss The Journal of General Physiology Muscle FunctionCytoskeletonMechanotransductionPca 4.5Cellular Physiology	1989	290
A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy Jennifer Davis, Lindsay Davis, Robert N. Correll, Cell MechanobiologyCardiac MuscleCardiomyopathyHeart FailureEngineering	2016	253

Page 1